The French-speaking Diabetes Society is seeking the expertise of three leaders in the French biobanking ecosystem to accelerate the identification of new factors associated with major cardiovascular events (MACE*) in patients.
*(major adverse cardiovascular events)
CREAPHARM BIOSERVICES has recently invested in -80°C nitrogen tanks to provide Biotechs and Research key players with a new solution to meet the challenges of ultra-low temperature storage.
CREAPHARM BIOSERVICES announces its investment in -80°C nitrogen tanks to provide the European
ultra-low temperature storage market with unparalleled performance.